Stockscreener 앱 받기
5.51
1.10%
0.06
전일 마감가:
$5.45
열려 있는:
$5.51
하루 거래량:
12,379
Relative Volume:
0.70
시가총액:
$54.92M
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
+4.16%
1개월 성능:
+4.36%
6개월 성능:
+22.17%
1년 성능:
+0.00%
1일 변동 폭
$5.2214
$5.53
1주일 범위
$5.0201
$5.54
52주 변동 폭
$3.81
$10.28
Serina Therapeutics Inc Stock (SER) Company Profile
명칭
Serina Therapeutics Inc
전화
(256) 327-9630
주소
601 GENOME WAY, HUNTSVILLE
SER을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SER
Serina Therapeutics Inc
|
5.51 | 52.43M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
366.54 | 98.88B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.00 | 58.84B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
438.93 | 56.12B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
661.83 | 41.20B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
288.18 | 35.49B | 3.81B | -644.79M | -669.77M | -6.24 |
Serina Therapeutics Inc Stock (SER) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-14 | 개시 | H.C. Wainwright | Buy |
Serina Therapeutics Inc 주식(SER)의 최신 뉴스
Does Serina Therapeutics Inc. show high probability of reboundDay Trading Setup Forecast with Trend Model - Newser
What makes Serina Therapeutics Inc. stock price move sharplyPrice Action Based Buy Zone Forecast - Newser
Analyzing net buyer seller activity in Serina Therapeutics Inc.Multi-Year Signal Summary and Entry Timing - Newser
Risk adjusted return profile for Serina Therapeutics Inc. analyzedMarket Opportunity Tracker for Swing Traders - Newser
Is Serina Therapeutics Inc. stock reversal real or fakeSector Rotation and Stock Opportunity Analysis - Newser
Is Serina Therapeutics Inc. stock entering bullish territorySwing Candidate List with Trade Cues - Newser
Is Serina Therapeutics Inc. stock a growth or value playFree Reliable Chart-Based Trade Entries - Newser
Can Serina Therapeutics Inc. recover in the next quarterLong-Term Signal Tracking and Profit Summary - Newser
Volume spikes in Serina Therapeutics Inc. stock – what they meanLong-Term Trend Tracking and Signal Summary - Newser
Why Serina Therapeutics Inc. stock attracts strong analyst attentionMinimal Risk Growth Investment Opportunity Analysis - Newser
Serina Therapeutics CSO sells $28,435 in shares - Investing.com
Serina Therapeutics CSO sells $28,435 in shares By Investing.com - Investing.com Canada
Serina Therapeutics CSO Moreadith Randall sells and buys shares on 2025-08-04. - AInvest
What moving averages say about Serina Therapeutics Inc.Stable Swing Setup with Safety Analysis - Newser
Real time breakdown of Serina Therapeutics Inc. stock performanceFree High Yield Stock Screening Results - Newser
Competitive Positioning of Serina Therapeutics Inc.: Is It Leading or LaggingAI-Powered Stock Trend Movement Analysis - Newser
Analyzing recovery setups for Serina Therapeutics Inc. investorsFree Daily Growth Stock Pick Reports - Newser
Serina Therapeutics Inc. recovery potential after sell offTechnical Entry Plan with Risk Minimization - Newser
How strong is Serina Therapeutics Inc. company’s balance sheetAchieve rapid portfolio appreciation today - Jammu Links News
Is Serina Therapeutics Inc. stock overvalued or undervaluedFree Capital Efficiency Planning - Jammu Links News
Is Serina Therapeutics Inc. a good long term investmentInvest smarter with daily market updates - Jammu Links News
Is Serina Therapeutics Inc. a growth stock or a value stockFree Market Dynamics Reports - Jammu Links News
What are the latest earnings results for Serina Therapeutics Inc.Free High-Return Strategy Alerts - Jammu Links News
When is Serina Therapeutics Inc. stock expected to show significant growthFree Stock Selection - Jammu Links News
Should I hold or sell Serina Therapeutics Inc. stock in 2025Tremendous return rates - Jammu Links News
Does Serina Therapeutics Inc. stock perform well during market downturnsDiscover undervalued opportunities early - Jammu Links News
What catalysts could drive Serina Therapeutics Inc. stock higher in 2025Unlock powerful portfolio management tools - Jammu Links News
What is Serina Therapeutics Inc. company’s growth strategyHigh-yield portfolio picks - Jammu Links News
Visualizing Serina Therapeutics Inc. stock with heatmapsIntraday Signal Forecast for Fast Traders - Newser
How Serina Therapeutics Inc. stock performs during market volatilityFree Swing Setup With Technical Confirmation - Newser
Is it the right time to buy Serina Therapeutics Inc. stockEntry Signal Forecasts With Low Risk - Jammu Links News
How sentiment analysis helps forecast Serina Therapeutics Inc.Free Swing Trading Entry Point Signals - Newser
Serina Therapeutics CSO sells $27,274 in stock - Investing.com Australia
Serina Therapeutics CSO sells $27,274 in stock By Investing.com - Investing.com South Africa
Serina Therapeutics Advances SER-270 for Tardive Dyskinesia - The Globe and Mail
Serina Therapeutics Inc (SER) 재무 분석
Serina Therapeutics Inc (SER)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
0.24%
3.39%
자본화:
|
볼륨(24시간):